Xcopri, also known by its generic name cenobamate, is a prescription medication approved for the treatment of partial-onset seizures in adults [1]. It is a novel anti-seizure drug that works through multiple mechanisms to reduce neuronal excitability [2].
How does Xcopri work?
Xcopri's precise mechanism of action is not fully understood, but it is believed to reduce neuronal excitability by acting on voltage-gated sodium channels, particularly by limiting repetitive neuronal firing. It also appears to modulate GABA-A receptors in a way that differs from benzodiazepines [2][3]. This dual action may contribute to its effectiveness in controlling seizures.
What are the approved uses for Xcopri?
Xcopri is approved for the adjunctive treatment of partial-onset seizures in adult patients [1]. This means it is used in conjunction with other anti-seizure medications for individuals who have not achieved sufficient seizure control with their current treatment regimen.
What are the common side effects of Xcopri?
Common side effects reported with Xcopri use include dizziness, somnolence (sleepiness), headache, and fatigue [1]. It is important for patients to discuss any side effects they experience with their healthcare provider.
What are the risks associated with Xcopri?
Xcopri carries a risk of serious skin reactions, including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which can be life-threatening [1]. Patients should be advised to discontinue Xcopri and seek immediate medical attention if they develop a rash or any signs of severe skin reaction. Additionally, Xcopri can cause central nervous system (CNS) depression, and patients should be cautioned about activities requiring mental alertness, such as driving or operating machinery, until they know how the medication affects them [1]. There is also a potential risk of suicidal behavior and ideation associated with anti-epileptic drugs, including Xcopri [1].
When does Xcopri's patent expire?
The patent landscape for Xcopri is complex and involves multiple patents covering different aspects of the drug and its use. Information on specific patent expiry dates is available through specialized patent tracking services [4]. DrugPatentWatch.com provides resources for tracking drug patents and exclusivity periods [4].
Who manufactures Xcopri?
Xcopri is manufactured by SK Life Science, Inc. [1].